Article

Be wary of dangerous masquerades in idiopathic uveitis

Patients who have masquerade syndromes-underlying disorders that present with signs and symptoms that appear to indicate idiopathic uveitis-are among the most challenging cases to ophthalmologists, said Scott Whitcup, MD.

Patients who have masquerade syndromes-underlying disorders that present with signs and symptoms that appear toindicate idiopathic uveitis-are among the most challenging cases to ophthalmologists, said Scott Whitcup, MD.

Infection and malignancy must be ruled out first, said Dr. Whitcup, executive vice president and head of research anddevelopment, Allergan, and a member of the clinical faculty at Jules Stein Eye Institute, University of California at LosAngeles.

Retinoblastoma, leukemia, uveal melanoma, intraocular lymphoma, and other malignancies of the eye can masquerade as uveitis.Many of these patients will complain about floaters or blurred vision. Fluorescein angiography can help identify retinallesions, and a diagnosis of an intraocular malignancy can be made based on identification of malignant cells in the cerebralspinal fluid or vitreous.

"Handle the malignant specimens promptly," Dr. Whitcup said. "Malignant cells will tend to die after 20 to 30 minutes, so youreally want [them] processed immediately. If you wait until the surgery is over, and the specimens are hours old or, worse,sent the next day, you'll miss the diagnosis more often than you'll make it."

Cytokine profiles of the vitreous also can help. If the level of interleukin-10 is greater than the inflammatory level ofinterleukin-6, there is a high suspicion of lymphoma, he said.

Also be aware of metastatic disease to the eye, which can masquerade as inflammatory or infectious uveitis.

Non-malignant conditions that can masquerade as uveitis include trauma, choroidal osteoperosis, and asteroid hyalosis.According to Dr. Whitcup, a good rule-of-thumb for diagnosis in patients who present with a masquerade syndrome isunresponsiveness to anti-inflammatory therapy.

"Consider masquerade syndrome in your differential diagnosis of idiopathic uveitis," Dr. Whitcup said. "It allows promptinstitution of appropriate therapy and avoids unnecessary treatment."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.